HTR7P1 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 6.304100E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
8.996300E-02
Normal-vs-Stage2
6.833900E-02
Normal-vs-Stage3
2.315200E-01
Normal-vs-Stage4
3.594000E-01
Stage1-vs-Stage2
7.444200E-01
Stage1-vs-Stage3
8.830000E-01
Stage1-vs-Stage4
8.978400E-01
Stage2-vs-Stage3
6.677600E-01
Stage2-vs-Stage4
6.639600E-01
Stage3-vs-Stage4
9.958000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
5.035700E-02
Normal-vs-AfricanAmerican
1.216220E-01
Normal-vs-Asian
2.393800E-01
Caucasian-vs-AfricanAmerican
9.794600E-01
Caucasian-vs-Asian
8.271600E-01
AfricanAmerican-vs-Asian
8.927800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
3.829800E-02
Normal-vs-Female
1.157400E-01
Male-vs-Female
7.058100E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
2.647400E-01
Normal-vs-Age(41-60Yrs)
2.877400E-01
Normal-vs-Age(61-80Yrs)
1.624080E-02
Normal-vs-Age(81-100Yrs)
5.076400E-03
Age(21-40Yrs)-vs-Age(41-60Yrs)
9.743200E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
3.923400E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
2.880600E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.467980E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
4.262200E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
8.490000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
2.276400E-02
Normal-vs-Daily Drinker
3.284200E-03
Normal-vs-Weekly Drinker
5.896200E-02
Normal-vs-Occasional Drinker
2.709200E-01
Normal-vs-Social Drinker
5.207400E-01
Non Drinker-vs-Daily Drinker
6.145800E-01
Non Drinker-vs-Weekly Drinker
3.877200E-01
Non Drinker-vs-Occasional Drinker
1.698180E-01
Non Drinker-vs-Social Drinker
1.452980E-01
Daily Drinker-vs-Weekly Drinker
1.656570E-01
Daily Drinker-vs-Occasional Drinker
1.053390E-01
Daily Drinker-vs-Social Drinker
8.698500E-02
Weekly Drinker-vs-Occasional Drinker
6.317200E-01
Weekly Drinker-vs-Social Drinker
3.775600E-01
Occasional Drinker-vs-Social Drinker
6.440000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
9.930000E-01
Normal-vs-Grade 2
6.292600E-01
Normal-vs-Grade 3
6.273000E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
9.644100E-02
Grade 1-vs-Grade 3
1.127160E-01
Grade 1-vs-Grade 4
9.930000E-01
Grade 2-vs-Grade 3
8.101200E-01
Grade 2-vs-Grade 4
6.292600E-01
Grade 3-vs-Grade 4
6.273000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
1.046370E-02
Normal-vs-NonDiabetic
8.547900E-02
Diabetic-vs-NonDiabetic
2.981400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
2.659600E-01
Normal-vs-NoPancreatitis
4.891700E-02
Pancreatitis-vs-NoPancreatitis
9.696600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
8.570000E-02
Normal-vs-N1
3.482000E-02
N0-vs-N1
8.250400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
1.112000E-01
Normal-vs-TP53-NonMutant
6.942300E-02
TP53-Mutant-vs-TP53-NonMutant
7.715000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
